Freedman Financial Associates, Inc. Cara Therapeutics, Inc. Transaction History

Freedman Financial Associates, Inc.

  • $0
  • Q2 2022

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 12, 2022
SELL
$7.45 - $13.84 $24,830 - $46,128
-3,333 Closed
0 $0
Q4 2021

Jan 14, 2022
SELL
$11.99 - $18.14 $2,002 - $3,029
-167 Reduced 4.77%
3,333 $41,000
Q2 2021

Jul 13, 2021
SELL
$12.38 - $29.19 $23,522 - $55,461
-1,900 Reduced 35.19%
3,500 $50,000
Q4 2020

Feb 17, 2021
BUY
$12.72 - $16.16 $68,688 - $87,264
5,400 New
5,400 $82,000

Others Institutions Holding CARA

# of Institutions
102
Shares Held
21.5M
Call Options Held
50K
Put Options Held
0
View Full List

About Cara Therapeutics, Inc.

CARA Quotes by TradingView
  • Ticker CARA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 53,725,900
  • Market Cap $14M
  • Description
  • Cara Therapeutics, Inc., an early commercial-stage biopharmaceutical company, focuses on developing and commercializing chemical entities with a primary focus on pruritus and pain by selectively targeting kappa opioid receptors in the United States. The company is developing product candidates that target the body's peripheral nervous system and...
More about CARA
Track This Portfolio

Track Freedman Financial Associates, Inc. Portfolio

Follow Freedman Financial Associates, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Freedman Financial Associates, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Freedman Financial Associates, Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email